{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:31:53Z","timestamp":1791153113126,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.jsbmb.2003.12.004","type":"journal-article","created":{"date-parts":[[2004,3,20]],"date-time":"2004-03-20T12:09:07Z","timestamp":1079784547000},"page":"277-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["In vitro antiprogestational\/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone"],"prefix":"10.1016","volume":"88","author":[{"given":"Barbara J.","family":"Attardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Burgenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri A.","family":"Hild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry R.","family":"Reel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2003.12.004_BIB1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0039-128X(84)80027-6","article-title":"New steroids with antiprogestational and antiglucocorticoid activities","volume":"44","author":"Neef","year":"1984","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0022-4731(88)90007-6","article-title":"Screening of antiprogestagens by receptor studies and bioassays","volume":"31","author":"Kloosterboer","year":"1988","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/humrep\/9.suppl_1.12","article-title":"History and perspectives of antiprogestins from the chemist\u2019s point of view","volume":"9","author":"Teutsch","year":"1994","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.pa.36.040196.000403","article-title":"Antiprogestins: mechanism of action and contraceptive potential","volume":"36","author":"Spitz","year":"1996","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.med.48.1.129","article-title":"RU486 (MIFEPRISTONE): mechanisms of action and clinical uses","volume":"48","author":"Cadepond","year":"1997","journal-title":"Ann. Rev. Med."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-4731(86)90242-6","article-title":"Analysis of the relation between receptor binding affinity and antagonist efficacy of antiglucocorticoids","volume":"25","author":"Gagne","year":"1986","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0014-4827(87)90282-5","article-title":"Antagonist effect of RU486 on transcription of glucocorticoid-regulated genes","volume":"173","author":"Busso","year":"1987","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB8","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/humrep\/15.4.822","article-title":"CDB-2914: anti-progestational\/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits","volume":"15","author":"Hild","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB9","unstructured":"B.J. Attardi, S.A. Hild, J.R. Reel, R.P. Blye, CDB-4124 [17\u03b1-acetoxy-11\u03b2-(4-N,N-dimethylaminophenyl)-21-methoxy-19-norpregna-4,9-diene-3,20-dione]: a potent antiprogestin with antiovulatory and postcoital antifertility activity, in: Proceedings of the Program of the 82nd Annual Meeting of the Endocrine Society (Abstract 1293), Toronto, Canada, 2000."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0303-7207(01)00743-2","article-title":"CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914","volume":"188","author":"Attardi","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB11","doi-asserted-by":"crossref","unstructured":"R. Deraedt, C. Bonnat, M. Busigny, C. Cousty, M. Mouren, D. Philibert, J. Pottier, J. Salmon, Pharmacokinetics of RU486, in: E.E. Baulieu, S. Segal (Eds.), The Antiprogestin Steroid RU486 and Human Fertility Control, Plenum Press, New York, 1985, pp. 103\u2013122.","DOI":"10.1007\/978-1-4684-1242-0_9"},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB12","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1210\/mend-5-11-1755","article-title":"Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system","volume":"5","author":"Christensen","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB13","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1210\/endo-116-6-2236","article-title":"The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47D-CO human breast cancer cells","volume":"116","author":"Horwitz","year":"1985","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0960-0760(94)90254-2","article-title":"Estrogenic and progestagenic activities coexisting in steroidal drugs: quantitative evaluation by in vitro bioassays with human cells","volume":"48","author":"Markiewicz","year":"1993","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1113\/jphysiol.1934.sp003217","article-title":"The assay of progestin","volume":"83","author":"McPhail","year":"1934","journal-title":"J. Physiol. Lond."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1210\/endo-24-6-829","article-title":"Effect of local application of progesterone on the rabbit uterus","volume":"24","author":"McGinty","year":"1939","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0026-0495(64)80007-X","article-title":"Biological potencies of chemically modified adrenocorticosteroids in rats and man","volume":"13","author":"Ringler","year":"1964","journal-title":"Metabolism"},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB19","doi-asserted-by":"crossref","first-page":"14196","DOI":"10.1016\/S0021-9258(18)89877-5","article-title":"The rabbit progesterone receptor. Evidence for a single steroid-binding subunit and characterization of receptor mRNA","volume":"259","author":"Loosfelt","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003088-199733010-00002","article-title":"Clinical pharmacokinetics of mifepristone","volume":"1","author":"Heikinheimo","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/oxfordjournals.humrep.a136554","article-title":"Metabolism and serum binding of RU 486 in women after various single doses","volume":"2","author":"Heikinheimo","year":"1987","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0010-7824(93)90004-Q","article-title":"Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women","volume":"48","author":"Shi","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB23","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/0006-291X(90)90661-6","article-title":"The steroid antagonist RU38486 is metabolized by the liver microsomal P450 mono-oxygenases","volume":"167","author":"Chasserot-Golaz","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB24","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/0006-2952(93)90654-F","article-title":"Biotransformation of 17\u03b2-hydroxy-11\u03b1-(4-dimethylaminophenyl)17\u03b1-1-propynyl-estra-4,9-dien-3-one (RU486) in rat hepatoma variants","volume":"46","author":"Chasserot-Golaz","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0006-2952(96)00357-7","article-title":"Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in rat liver microsomes","volume":"52","author":"Jang","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB26","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/humrep\/15.5.1100","article-title":"Circulating concentrations of the antiprogestins CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration","volume":"15","author":"Larner","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB27","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0039-128X(03)00130-2","article-title":"Pharmacologic properties of CDB(VA)-2914","volume":"68","author":"Gainer","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0022-4731(87)90083-5","article-title":"Plasma concentrations and receptor binding of RU 486 and its metabolites in humans","volume":"26","author":"Heikinheimo","year":"1987","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2003.12.004_BIB29","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1210\/endo.140.3.6581","article-title":"The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: implications for the development of dissociated antiprogestins","volume":"140","author":"Wagner","year":"1999","journal-title":"Endocrinology"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076004000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076004000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:45:46Z","timestamp":1760733946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076004000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0960076004000184"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2003.12.004","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antiprogestational\/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2003.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}